BC Innovations | Jun 7, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: May 2018

New Therapeutic Targets and Biomarkers: May 2018 Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database during May 2018. Therapeutic targets are defined as any protein, gene or other...
BC Innovations | May 30, 2018
Distillery Therapeutics

Cancer

INDICATION: Colorectal cancer Patient sample, cell culture and mouse studies suggest promoting expression of the miR-371-373 cluster encoding miR-371, miR-372 and miR-373 or inhibiting the TGFβ-RII/ID1 axis could help treat colorectal cancer. In colorectal cancer...
BC Innovations | Sep 1, 2016
Distillery Therapeutics

Therapeutics: Peroxiredoxin 6 (PRDX6); microRNA 371-3p (miR-371-3p)

Cancer INDICATION: Lung cancer Patient sample, cell culture and mouse studies suggest promoting expression of miR-371-3p or inhibiting PRDX6 could help treat Tarceva erlotinib-resistant lung and other cancers. In patients with lung, colorectal, gastric or...
BC Innovations | Nov 18, 2010
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Liver cancer MicroRNA-100 (miR-100); miRNA-let7a-2 (MIRLET7a2; LET-7a2); miR-371; miR-373 Studies in primary tumors suggest that a signature of four miRNAs could help guide treatment for...
Items per page:
1 - 4 of 4